✦ LIBER ✦

B094 Melphalan, Prednisone and Lenalidomide: Kinetics of Hematologic Toxicity and Time to Event Results

✍ Scribed by Palumbo, A; Zeldis, JB; Boccadoro, M; Petrucci, MT; Falco, P; Gay, F; Corradini, P; Morabito, F; Falcone, A; Di Raimondo, F; Crippa, C; Gozzetti, A; Nozza, A; Canepa, L; Knight, R

Book ID: 118629429
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 85 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70657-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melphalan, Prednisone, and Lenalidomide

Melphalan, Prednisone, and Lenalidomide for Newly Diagnosed Myeloma: Kinetics of Neutropenia and Thrombocytopenia and Time-to-Event Results

✍ Palumbo, Antonio; Falco, Patrizia; Falcone, Antonietta; Benevolo, Giulia; Canepa 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 123 KB

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB